학술논문
Cost-utility analysis of Palbociclib plus letrozole and ribociclib plus letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival model
Document Type
Journal
Source
Subject
Language
English
ISSN
21911991